Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1997 Sep;71(9):6967–6972. doi: 10.1128/jvi.71.9.6967-6972.1997

Functional interactions between monomers of the retroviral envelope protein complex.

Y Zhao 1, S Lee 1, W F Anderson 1
PMCID: PMC191981  PMID: 9261425

Abstract

Retroviral vectors have been widely used in human gene therapy protocols. Entry into target cells is directed by the retroviral envelope protein, with receptor binding and postbinding fusion functions contributed mainly by the SU and TM subunits, respectively. We have generated mutants of the Moloney murine leukemia virus (MoMuLV) envelope protein with mutations in both the receptor binding domain of SU and throughout the TM subunit that are functionally inactive when expressed individually. However, the coexpression of these two classes of mutants partially restores envelope protein function and allows transduction. Several lines of evidence indicate that this complementation occurs in trans within envelope protein heterooligomers. The finding that the binding and postbinding functions of a retroviral envelope protein can be contributed by two different monomers should assist in the engineering of envelope proteins for tissue-specific gene delivery.

Full Text

The Full Text of this article is available as a PDF (624.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battini J. L., Danos O., Heard J. M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol. 1995 Feb;69(2):713–719. doi: 10.1128/jvi.69.2.713-719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Battini J. L., Heard J. M., Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol. 1992 Mar;66(3):1468–1475. doi: 10.1128/jvi.66.3.1468-1475.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 1994 Sep 1;371(6492):37–43. doi: 10.1038/371037a0. [DOI] [PubMed] [Google Scholar]
  4. Carr C. M., Kim P. S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 1993 May 21;73(4):823–832. doi: 10.1016/0092-8674(93)90260-w. [DOI] [PubMed] [Google Scholar]
  5. Chu T. H., Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol. 1995 Apr;69(4):2659–2663. doi: 10.1128/jvi.69.4.2659-2663.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cosset F. L., Morling F. J., Takeuchi Y., Weiss R. A., Collins M. K., Russell S. J. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol. 1995 Oct;69(10):6314–6322. doi: 10.1128/jvi.69.10.6314-6322.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doms R. W., Lamb R. A., Rose J. K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 1993 Apr;193(2):545–562. doi: 10.1006/viro.1993.1164. [DOI] [PubMed] [Google Scholar]
  8. Fass D., Harrison S. C., Kim P. S. Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol. 1996 May;3(5):465–469. doi: 10.1038/nsb0596-465. [DOI] [PubMed] [Google Scholar]
  9. Fass D., Kim P. S. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol. 1995 Dec 1;5(12):1377–1383. doi: 10.1016/s0960-9822(95)00275-2. [DOI] [PubMed] [Google Scholar]
  10. Freed E. O., Delwart E. L., Buchschacher G. L., Jr, Panganiban A. T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70–74. doi: 10.1073/pnas.89.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Freed E. O., Risser R. The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol. 1987 Sep;61(9):2852–2856. doi: 10.1128/jvi.61.9.2852-2856.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Green N., Shinnick T. M., Witte O., Ponticelli A., Sutcliffe J. G., Lerner R. A. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6023–6027. doi: 10.1073/pnas.78.10.6023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Han X., Kasahara N., Kan Y. W. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9747–9751. doi: 10.1073/pnas.92.21.9747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Heard J. M., Danos O. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol. 1991 Aug;65(8):4026–4032. doi: 10.1128/jvi.65.8.4026-4032.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jones J. S., Risser R. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J Virol. 1993 Jan;67(1):67–74. doi: 10.1128/jvi.67.1.67-74.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kadan M. J., Sturm S., Anderson W. F., Eglitis M. A. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J Virol. 1992 Apr;66(4):2281–2287. doi: 10.1128/jvi.66.4.2281-2287.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kamps C. A., Lin Y. C., Wong P. K. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology. 1991 Oct;184(2):687–694. doi: 10.1016/0042-6822(91)90438-h. [DOI] [PubMed] [Google Scholar]
  18. Kasahara N., Dozy A. M., Kan Y. W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 1994 Nov 25;266(5189):1373–1376. doi: 10.1126/science.7973726. [DOI] [PubMed] [Google Scholar]
  19. MacKrell A. J., Soong N. W., Curtis C. M., Anderson W. F. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol. 1996 Mar;70(3):1768–1774. doi: 10.1128/jvi.70.3.1768-1774.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morgan R. A., Nussbaum O., Muenchau D. D., Shu L., Couture L., Anderson W. F. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol. 1993 Aug;67(8):4712–4721. doi: 10.1128/jvi.67.8.4712-4721.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ott D., Friedrich R., Rein A. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol. 1990 Feb;64(2):757–766. doi: 10.1128/jvi.64.2.757-766.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pinter A., Honnen W. J., Tung J. S., O'Donnell P. V., Hämmerling U. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology. 1982 Jan 30;116(2):499–516. doi: 10.1016/0042-6822(82)90143-x. [DOI] [PubMed] [Google Scholar]
  23. Ragheb J. A., Anderson W. F. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol. 1994 May;68(5):3207–3219. doi: 10.1128/jvi.68.5.3207-3219.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ragheb J. A., Anderson W. F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol. 1994 May;68(5):3220–3231. doi: 10.1128/jvi.68.5.3220-3231.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ramsdale E. E., Kingsman S. M., Kingsman A. J. The "putative" leucine zipper region of murine leukemia virus transmembrane protein (P15e) is essential for viral infectivity. Virology. 1996 Jun 1;220(1):100–108. doi: 10.1006/viro.1996.0290. [DOI] [PubMed] [Google Scholar]
  26. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol. 1994 Mar;68(3):1773–1781. doi: 10.1128/jvi.68.3.1773-1781.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Salmons B., Günzburg W. H. Targeting of retroviral vectors for gene therapy. Hum Gene Ther. 1993 Apr;4(2):129–141. doi: 10.1089/hum.1993.4.2-129. [DOI] [PubMed] [Google Scholar]
  28. Somia N. V., Zoppé M., Verma I. M. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7570–7574. doi: 10.1073/pnas.92.16.7570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Spies C. P., Ritter G. D., Jr, Mulligan M. J., Compans R. W. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol. 1994 Feb;68(2):585–591. doi: 10.1128/jvi.68.2.585-591.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. White J. M. Membrane fusion. Science. 1992 Nov 6;258(5084):917–924. doi: 10.1126/science.1439803. [DOI] [PubMed] [Google Scholar]
  31. Yu H., Soong N., Anderson W. F. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol. 1995 Oct;69(10):6557–6562. doi: 10.1128/jvi.69.10.6557-6562.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES